EOLS Evolus, Inc. Stock Quote

EOLS [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-3.77	Insider Own	26.30%	Shs Outstand	51.15M	Perf Week	6.26%
Market Cap	439.28M	Forward P/E	-	EPS next Y	-0.24	Insider Trans	-12.94%	Shs Float	35.98M	Perf Month	0.74%
Income	-131.40M	PEG	-	EPS next Q	-0.27	Inst Own	32.10%	Short Float	6.64%	Perf Quarter	-23.76%
Sales	76.60M	P/S	5.73	EPS this Y	-51.50%	Inst Trans	0.10%	Short Ratio	4.46	Perf Half Y	-12.79%
Book/sh	2.08	P/B	3.92	EPS next Y	75.30%	ROA	-63.90%	Target Price	16.86	Perf Year	136.92%
Cash/sh	2.44	P/C	3.34	EPS next 5Y	16.50%	ROE	-573.80%	52W Range	2.85 - 17.38	Perf YTD	142.56%
Dividend	-	P/FCF	-	EPS past 5Y	-29.70%	ROI	-251.10%	52W High	-53.11%	Beta	2.36
Dividend %	-	Quick Ratio	1.80	Sales past 5Y	-	Gross Margin	63.00%	52W Low	185.96%	ATR	0.45
Employees	130	Current Ratio	1.90	Sales Q/Q	234.60%	Oper. Margin	-	RSI (14)	52.94	Volatility	7.21% 6.14%
Optionable	Yes	Debt/Eq	0.18	EPS Q/Q	51.30%	Profit Margin	-	Rel Volume	0.45	Prev Close	8.05
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 02 BMO	Payout	-	Avg Volume	536.29K	Price	8.15
Recom	2.10	SMA20	7.60%	SMA50	-7.36%	SMA200	-19.30%	Volume	240,319	Change	1.24%

May-06-21

Upgrade

Mizuho

Neutral → Buy

$15

Apr-08-21

Reiterated

H.C. Wainwright

Buy

$20 → $22

Feb-24-21

Downgrade

Truist

Buy → Hold

$12

Jul-07-20

Downgrade

Mizuho

Buy → Neutral

$8 → $3

Feb-06-20

Resumed

Mizuho

Buy

Nov-26-19

Initiated

SVB Leerink

Outperform

$25

Sep-05-19

Resumed

Mizuho

Buy

$30

Jun-28-19

Initiated

Wells Fargo

Market Perform

$16

Jun-11-19

Initiated

Barclays

Underweight

$13

Mar-20-19

Initiated

SunTrust

Buy

$30

Feb-14-19

Initiated

H.C. Wainwright

Buy

$37

Jan-29-19

Initiated

Stifel

Buy

$27

Oct-22-21 09:00AM	Evolus to Report Third Quarter 2021 Results and Provide Business Update GlobeNewswire
Sep-23-21 08:58AM	What Kind Of Shareholders Own Evolus, Inc. (NASDAQ:EOLS)? Simply Wall St.
Sep-02-21 09:00AM	Evolus Announces Participation in September Investment Conferences GlobeNewswire
Aug-26-21 08:11AM	4 Stocks Insiders Are Buying Benzinga
Aug-18-21 08:52AM	4 Stocks Insiders Are Buying Benzinga
Aug-09-21 02:53AM	When Will Evolus, Inc. (NASDAQ:EOLS) Become Profitable? Simply Wall St.
Aug-04-21 06:05PM	Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM	Evolus Reports Second Quarter 2021 Results and Provides Business Update GlobeNewswire
Jul-28-21 03:04PM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-22-21 09:00AM	Evolus to Report Second Quarter 2021 Results and Provide Business Update GlobeNewswire
Jul-03-21 06:25AM	Can Evolus Disrupt the Botox Market? Motley Fool
Jun-30-21 09:00AM	Evolus Announces Appointment of David K. Erickson as Vice President, Investor Relations GlobeNewswire
Jun-25-21 04:51AM	Did Business Growth Power Evolus' (NASDAQ:EOLS) Share Price Gain of 149%? Simply Wall St.
Jun-24-21 09:00AM	Peer Reviewed Article Highlights Efficacy and Safety of Jeuveau® in Patients with Skin of Color GlobeNewswire
May-19-21 09:00AM	Evolus Appoints Dan Stewart as Vice President and General Manager, International GlobeNewswire
May-12-21 04:05PM	Evolus Reports First Quarter 2021 Results and Provides Business Update GlobeNewswire
02:30PM	Evolus, Inc. to Host Earnings Call ACCESSWIRE
10:33AM	Repeat Doses Of Evolus' Frown Lines Treatment Are Safe, With Decreasing Rates Of Adverse Events Benzinga
09:00AM	Aesthetic Surgery Journal Publishes Long Term Safety and Efficacy Data of Jeuveau® for the Treatment of Moderate to Severe Frown Lines GlobeNewswire
May-11-21 12:18PM	Aurora Cannabis (ACB) to Post Q3 Earnings: What's in Store? Zacks
May-10-21 08:24AM	Why Evolus (EOLS) Might Surprise This Earnings Season Zacks
May-04-21 04:05PM	Evolus to Report First Quarter 2021 Results and Provide Business Update GlobeNewswire
May-03-21 03:01PM	Evolus, Inc. (EOLS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release Zacks
Apr-29-21 04:05PM	Evolus to Participate in the 7th Annual Truist Securities Life Sciences Summit GlobeNewswire
Apr-22-21 06:02PM	Why Evolus Stock Dived by Almost 19% Today Motley Fool -18.86%
Apr-21-21 10:30PM	Evolus Announces Pricing of Public Offering of Common Stock GlobeNewswire +11.09%
04:01PM	Evolus Announces Proposed Public Offering of Common Stock GlobeNewswire
Mar-25-21 02:45AM	Evolus Slips 10% On Wider-Than-Expected 4Q Loss SmarterAnalyst -23.14%
Mar-24-21 05:35PM	Evolus, Inc. (EOLS) Reports Q4 Loss, Lags Revenue Estimates Zacks
04:05PM	Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update GlobeNewswire
Mar-23-21 01:52PM	Daewoong Pharmaceutical Injects More Liquidity In Evolus Benzinga +11.97%
09:21AM	Evolus to Report Fourth Quarter and Year End 2020 Results and Provide Business Update GlobeNewswire
09:17AM	Evolus Strengthens Balance Sheet Through a $25.5 Million Cash Infusion and Elimination of $127.4 Million of Debt and Milestone Payments GlobeNewswire
Mar-02-21 04:05PM	Evolus to Participate in Two Upcoming Investor Conferences GlobeNewswire +12.07%
Mar-01-21 09:41AM	Is a Surprise Coming for Evolus (EOLS) This Earnings Season? Zacks
Feb-26-21 09:00AM	Evolus Announces Promotion of Crystal Muilenburg to Chief Marketing Officer GlobeNewswire +5.30%
Feb-23-21 09:00AM	Evolus Announces Preliminary, Unaudited, Fourth Quarter and Full Year 2020 Net Revenue GlobeNewswire -10.28%
Feb-19-21 04:05PM	EOLS Stock: The Big News That Has Evolus Shares Skyrocketing Today InvestorPlace +71.65%
04:05PM	Evolus to Participate in the 10th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
10:42AM	Evolus Shares Surge After Settling Jeuveau Related Litigation With AbbVie, Medytox Benzinga
09:15AM	AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation PR Newswire
Feb-17-21 02:15AM	When Can We Expect A Profit From Evolus, Inc. (NASDAQ:EOLS)? Simply Wall St.
Jan-28-21 08:44AM	Do Options Traders Know Something About Evolus (EOLS) Stock We Don't? Zacks
Dec-19-20 01:04AM	Analysts Have Just Cut Their Evolus, Inc. (NASDAQ:EOLS) Revenue Estimates By 23% Simply Wall St.
Dec-17-20 08:10AM	The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut Benzinga +21.53%
Dec-16-20 05:45PM	Evolus Provides Update on United States International Trade Commission (ITC) Case GlobeNewswire -8.93%
Dec-15-20 03:00PM	EOLS Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020 ACCESSWIRE
10:00AM	EOLS Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020 Newsfile
09:27AM	EOLS FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Reminds Evolus, Inc. Investors of Important December 15 Deadline in Securities Class Action EOLS GlobeNewswire
Dec-14-20 08:23PM	Evolus Deadline Alert Newsfile
01:00PM	DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Evolus, Inc. (EOLS) PR Newswire
12:15PM	FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
11:00AM	EOLS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020 Business Wire
11:00AM	DEADLINE ALERT for BMWYY, ZSAN, WFC, and EOLS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:52AM	DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:49AM	EOLS Final Deadline Tomorrow: Rosen, A Global and Leading Law Firm, Reminds Evolus, Inc. Investors of Important December 15 Deadline in Securities Class Action - EOLS Newsfile
08:00AM	Evolus, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law GlobeNewswire
Dec-13-20 12:30PM	EOLS Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020 ACCESSWIRE
10:59AM	Evolus Shareholder Alert Newsfile
Dec-12-20 02:00PM	DECEMBER 15 FINAL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
10:55AM	Evolus Deadline Alert Newsfile
Dec-11-20 09:00PM	DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Evolus, Inc. and Encourages Investors to Contact the Firm GlobeNewswire
03:10PM	IMMINENT FINAL DEADLINE: Top Ranked Rosen Law Firm Reminds Evolus, Inc. Investors of Important December 15 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - EOLS ACCESSWIRE
02:00PM	FINAL DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
11:30AM	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Evolus, Inc. (EOLS) Business Wire
11:00AM	RETA, EOLS & TRQ Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
10:27AM	DEADLINE TUESDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Dec-10-20 09:34PM	Evolus Class Action Reminder Newsfile
05:00PM	EOLS FINAL DEADLINE NOTICE: Top Ranked Rosen Law Firm Reminds Evolus, Inc. Investors of Important December 15 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm EOLS GlobeNewswire
10:25AM	TUESDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Dec-09-20 09:22PM	Evolus Shareholder Notice Newsfile
12:00PM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Evolus, Inc. (EOLS) GlobeNewswire
11:58AM	SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Reminds Investors of Important December 15 Deadline in Securities Class Action Lawsuit against Evolus Inc.; Encourages Investors with Losses in Excess of $50,000 to Contact the Firm GlobeNewswire
11:35AM	FINAL DEADLINE DECEMBER 15: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:00AM	RETA, EOLS & TRQ Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm GlobeNewswire
10:23AM	TUESDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Dec-08-20 09:21PM	Evolus Shareholder Alert Newsfile
08:00PM	DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Evolus, Inc. and Encourages Investors to Contact the Firm Business Wire
12:20PM	DECEMBER 15 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:15AM	DEADLINE ALERT for LOOP, TRQ, and EOLS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:07AM	TUESDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
12:30AM	FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Dec-07-20 09:01PM	Evolus Deadline Alert Newsfile
08:10PM	ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Evolus, Inc. Investors of Important December 15 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm EOLS Business Wire
12:30PM	DEADLINE ALERT for EOLS, LVS, IPHA, JPM: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:00AM	RETA, EOLS & TRQ Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
10:06AM	7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Dec-06-20 11:45AM	Evolus Lead Plaintiff Deadline Alert Newsfile
Dec-04-20 09:35PM	Evolus Update Newsfile
04:40PM	Rosen, A Top Ranked Law Firm, Reminds Evolus, Inc. Investors of Important December 15 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - EOLS Newsfile
08:00AM	Evolus, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law GlobeNewswire
Dec-03-20 09:33PM	Evolus Class Action Reminder Newsfile
05:29PM	ROSEN, A LEADING LAW FIRM, Reminds Evolus, Inc. Investors of Important December 15 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm EOLS GlobeNewswire
01:00PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:15AM	EOLS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020 ACCESSWIRE
04:10AM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Evolus, Inc. of Class Action Lawsuit and Upcoming Deadline - EOLS PR Newswire
Dec-02-20 09:32PM	Evolus Shareholder Notice Newsfile
05:00PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Loop Industries, Turquoise Hill Resources, Reta Pharmaceuticals, and Evolus and Encourages Investors to Contact the Firm GlobeNewswire
Dec-01-20 11:58PM	ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Evolus, Inc. Investors of Important December 15 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - EOLS PR Newswire
09:31PM	Evolus Shareholder Alert Newsfile

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was founded in 2012 and is headquartered in Newport Beach, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Alphaeon 1 LLC	10% Owner	Sep 02	Sale	9.50	2,597,475	24,676,012	6,064,871	Sep 07 05:37 PM
Medytox Inc.	10% Owner	Aug 27	Buy	10.93	51,000	557,568	7,463,652	Aug 31 04:19 PM
Medytox Inc.	10% Owner	Aug 26	Buy	11.02	66,000	727,406	7,412,652	Aug 27 04:21 PM
Medytox Inc.	10% Owner	Aug 25	Buy	11.12	44,000	489,386	7,346,652	Aug 27 04:21 PM
Medytox Inc.	10% Owner	Aug 24	Buy	11.17	72,219	807,033	7,302,652	Aug 25 04:21 PM
Medytox Inc.	10% Owner	Aug 23	Buy	11.03	69,781	769,775	7,230,433	Aug 25 04:21 PM
Malik Vikram	Director	Aug 23	Sale	11.00	26,077	286,722	1,143,701	Aug 25 06:37 PM
Medytox Inc.	10% Owner	Aug 20	Buy	10.56	48,000	506,698	7,160,652	Aug 23 04:26 PM
Malik Vikram	Director	Aug 20	Sale	10.61	49,878	529,315	1,169,778	Aug 20 08:19 PM
Medytox Inc.	10% Owner	Aug 19	Buy	10.51	55,000	578,110	7,112,652	Aug 23 04:26 PM
Malik Vikram	Director	Aug 19	Sale	10.50	11,962	125,556	1,219,656	Aug 20 08:19 PM
Medytox Inc.	10% Owner	Aug 18	Buy	10.54	45,000	474,075	7,057,652	Aug 19 04:15 PM
Malik Vikram	Director	Aug 18	Sale	10.44	25,000	261,012	1,231,618	Aug 19 07:01 PM
Medytox Inc.	10% Owner	Aug 17	Buy	10.69	70,000	748,062	7,012,652	Aug 19 04:15 PM
Malik Vikram	Director	Aug 17	Sale	10.06	42,083	423,549	1,256,618	Aug 19 07:01 PM
Medytox Inc.	10% Owner	Aug 16	Buy	11.34	65,000	737,035	6,942,652	Aug 17 04:10 PM
MOATAZEDI DAVID	See Remarks	Aug 16	Sale	11.35	47,737	541,739	377,072	Aug 17 08:24 PM
Medytox Inc.	10% Owner	Aug 13	Buy	10.98	49,714	545,716	6,877,652	Aug 17 04:10 PM
MOATAZEDI DAVID	See Remarks	Aug 13	Sale	10.66	22,708	242,072	424,809	Aug 17 08:24 PM
Medytox Inc.	10% Owner	Aug 12	Buy	10.93	39,126	427,714	6,827,938	Aug 13 04:33 PM
Medytox Inc.	10% Owner	Aug 11	Buy	10.77	26,160	281,738	6,788,812	Aug 13 04:33 PM
Avelar Rui	See Remarks	Aug 10	Sale	11.18	14,293	159,789	209,810	Aug 12 06:45 PM
MOATAZEDI DAVID	See Remarks	Jan 25	Sale	7.46	8,310	61,993	173,760	Jan 26 08:50 PM
Avelar Rui	See Remarks	Jan 25	Sale	7.46	2,699	20,135	134,103	Jan 26 08:50 PM
Jafar Michael M.	See Remarks	Jan 25	Sale	7.46	2,699	20,135	174,851	Jan 26 08:50 PM
SILVERNAIL LAUREN P	See Remarks	Jan 25	Sale	7.46	2,699	20,135	90,689	Jan 26 08:51 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience